Collagen Type IV (ABT165) IHC kit

    • Catalog No.:IHCM6941
    • Applications:IHC
    • Reactivity:Human (predicted: Mouse)
      • Target:
      • Collagen IV
      • Fields:
      • >>PI3K-Akt signaling pathway;>>Focal adhesion;>>ECM-receptor interaction;>>Relaxin signaling pathway;>>AGE-RAGE signaling pathway in diabetic complications;>>Protein digestion and absorption;>>Amoebiasis;>>Human papillomavirus infection;>>Pathways in cancer;>>Small cell lung cancer
      • Gene Name:
      • COL4A1
      • Protein Name:
      • Collagen Type IV
      • Human Gene Id:
      • 1282
      • Human Swiss Prot No:
      • P02462
      • Immunogen:
      • Synthesized peptide derived from human Collagen Type IV AA range: 1600-1669
      • Specificity:
      • The antibody can specifically recognize human Collagen Type IV protein, collagen types I, II, III and V do not respond to the anbody.. The antibody was also Predict react with Mouse
      • Source:
      • Mouse, Monoclonal/IgG2b, Kappa
      • Purification:
      • The antibody was affinity-purified from mouse ascites by affinity-chromatography using specific immunogen.
      • Storage Stability:
      • 2°C to 8°C/1 year
      • Other Name:
      • Collagen alpha-1(IV) chain [Cleaved into: Arresten]
      • Background:
      • This gene encodes a type IV collagen alpha protein. Type IV collagen proteins are integral components of basement membranes. This gene shares a bidirectional promoter with a paralogous gene on the opposite strand. The protein consists of an amino-terminal 7S domain, a triple-helix forming collagenous domain, and a carboxy-terminal non-collagenous domain. It functions as part of a heterotrimer and interacts with other extracellular matrix components such as perlecans, proteoglycans, and laminins. In addition, proteolytic cleavage of the non-collagenous carboxy-terminal domain results in a biologically active fragment known as arresten, which has anti-angiogenic and tumor suppressor properties. Mutations in this gene cause porencephaly, cerebrovascular disease, and renal and muscular defects. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Dec 2014],
      • Function:
      • disease:Defects in COL4A1 are a cause of brain small vessel disease with hemorrhage [MIM:607595]. Brain small vessel diseases underlie 20 to 30 percent of ischemic strokes and a larger proportion of intracerebral hemorrhages. Inheritance is autosomal dominant.,disease:Defects in COL4A1 are a cause of porencephaly type 1 [MIM:175780]; also known as encephaloclastic porencephaly. Porencephaly is a term used for any cavitation or cerebrospinal fluid-filled cyst in the brain. Porencephaly type 1 is usually unilateral and results from focal destructive lesions such as fetal vascular occlusion or birth trauma. Inheritance is autosomal dominant.,disease:Defects in COL4A1 are the cause of hereditary angiopathy with nephropathy, aneurysms, and muscle cramps (HANAC) [MIM:611773]. The clinical renal manifestations include hematuria and bilateral large cysts. Histologic analysis revealed complex bas
      • Subcellular Location:
      • Cytoplasmic
      • Expression:
      • Highly expressed in placenta.
      • Products Images
      • Human placenta tissue was stained with Anti-Collagen Type IV (ABT165) Antibody